Recent advances in organ chip (or,“organ-on-a-chip”) technologies and microphysiological
systems (MPS) have enabled in vitro investigation of endothelial cell function in biomimetic …

Engineered biomaterial scaffolds are becoming more prominent in research laboratories to
study drug efficacy for oncological applications in vitro, but do they have a place in …

The dysregulation of the immune system plays a crucial role in the pathogenesis of manyfold
diseases, among which we find rheumatoid arthritis (RA), an autoimmune disease …

Endothelial dysfunction is a critical feature of acute respiratory distress syndrome (ARDS)
associated with higher disease severity and worse outcomes. Preclinical in vivo models of …

The biology of cancer is characterized by an intricate interplay of cells originating not only
from the tumor mass, but also its surrounding environment. Different microbial species have …

Impressive advances have been made to replicate human physiology in vitro over the last
few years due to the growth of the organ-on-chip (OoC) field in both industrial and academic …

Microfluidic organ-on-chip systems are promising platforms for the development of
biomimetic models that aim to reconstruct the 3D architecture and intrinsic functionality of …

Abstract Organ‐On‐a‐Chip (OOC) is a multichannel 3D‐microfluidic cell‐culture system
incorporated in a chip that simulates the behavior of an organ. This technology relies on a …

Microfluidic technology plays a crucial role in organ-on-a-chip (OoC) systems by replicating
human physiological processes and disease states, significantly advancing biomedical …

Microfluidics technology has found numerous applications as an efficient and cost-effective
tool in biomedical engineering, where microfluidic devices have revolutionized biomedical …